Home Assessment of canonical diurnal variations in plasma glucose using quantile regression modelling and Chronomaps
Article
Licensed
Unlicensed Requires Authentication

Assessment of canonical diurnal variations in plasma glucose using quantile regression modelling and Chronomaps

  • Mustafa Özçürümez ORCID logo EMAIL logo , Jasmin Weninger , Abdurrahman Coskun ORCID logo , Farhad Arzideh ORCID logo , Thomas Streichert ORCID logo , Antje Torge , Jan-Peter Sowa ORCID logo , Christin Quast ORCID logo , Ali Canbay ORCID logo , Mario Plebani ORCID logo and Martina Broecker-Preuss ORCID logo
Published/Copyright: December 6, 2024

Abstract

Objectives

Diurnal variation of plasma glucose levels may contribute to diagnostic uncertainty. The permissible time interval, pT(t), was proposed as a time-dependent characteristic to specify the time within which glucose levels from two consecutive samples are not biased by the time of blood collection. A major obstacle is the lack of population-specific data that reflect the diurnal course of a measurand. To overcome this issue, an approach was developed to detect and assess diurnal courses from big data.

Methods

A quantile regression model, QRM, was developed comprising two-component cosinor analyses and time, age, and sex as predictors. Population-specific canonical diurnal courses were generated employing more than two million plasma glucose values from four different hospital laboratory sites. Permissible measurement uncertainties, pU, were also estimated by a population-specific approach to render Chronomaps that depict pT(t) for any timestamp of interest.

Results

The QRM revealed significant diurnal rhythmometrics with good agreement between the four sites. A minimum pT(t) of 3 h exists for median glucose levels that is independent from sampling times. However, amplitudes increase in a concentration-dependent manner and shorten pT(t) down to 72 min. Assessment of pT(t) in 793,048 paired follow-up samples from 99,453 patients revealed a portion of 24.2 % sample pairs that violated the indicated pT(t).

Conclusions

QRM is suitable to render Chronomaps from population specific time courses and suggest that more stringent sampling schedules are required, especially in patients with elevated glucose levels.


Corresponding author: Prof. Dr. med. Mustafa Özçürümez, Department of Medicine, University Hospital Knappschaftskrankenhaus Bochum GmbH, Ruhr-University Bochum, In der Schornau 23-25, 44892 Bochum, Germany, E-mail:

  1. Research ethics: Not applicable.

  2. Informed consent: Not applicable.

  3. Author contributions: Study concept and design: MÖ, FA, AC; Acquisition of data: MÖ, TS, AT, MP; Statistical analysis and graphical presentation: FA; Analysis and interpretation of data: MÖ, FA, JW, JPS, CQ, MBP; Drafting of the manuscript: FA, ACo, JPS, CQ, MBP. Critical revision of the manuscript for important intellectual content: JW, ACo, TS, AT, JPS, CQ, AC, MP, MBP. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: The raw data can be obtained on request from the corresponding author.

References

1. Aarsand, AK, Dı́az-Garzón, J, Fernandez-Calle, P, Guerra, E, Locatelli, M, Bartlett, WA, et al.. The EuBIVAS: within- and between-subject biological variation data for electrolytes, lipids, urea, uric acid, total protein, total bilirubin, direct bilirubin, and glucose. Clin Chem 2018;64:1380–93. https://doi.org/10.1373/clinchem.2018.288415.Search in Google Scholar PubMed

2. Özçürümez, MK, Coşkun, A, Arzideh, F, Streichert, T, Quast, C, Canbay, A, et al.. Time-dependent characteristics of analytical measurands. Clin Chem Lab Med 2024;62:2485–97. https://doi.org/10.1515/cclm-2023-1439.Search in Google Scholar PubMed

3. Sennels, HP, Jørgensen, HL, Fahrenkrug, J. Diurnal changes of biochemical metabolic markers in healthy young males–the Bispebjerg study of diurnal variations. Scand J Clin Lab Invest 2015;75:686–92. https://doi.org/10.3109/00365513.2015.1080385.Search in Google Scholar PubMed

4. Klerman, EB, Brager, A, Carskadon, MA, Depner, CM, Foster, R, Goel, N, et al.. Keeping an eye on circadian time in clinical research and medicine. Clin Transl Med 2022;12:e1131. https://doi.org/10.1002/ctm2.1131.Search in Google Scholar PubMed PubMed Central

5. Rietveld, WJ, Minors, DS, Waterhouse, JM. Circadian rhythms and masking: an overview. Chronobiol Int 1993;10:306–12. https://doi.org/10.3109/07420529309059713.Search in Google Scholar

6. ElSayed, NA, Aleppo, G, Bannuru, RR, Bruemmer, D, Collins, BS, Ekhlaspour, L, et al.. 2. Diagnosis and classification of diabetes: standards of care in diabetes–2024. Diabetes Care 2023;47:S20–42. https://doi.org/10.2337/dc24-s002.Search in Google Scholar PubMed PubMed Central

7. Kalsbeek, A, la Fleur, S, Fliers, E. Circadian control of glucose metabolism. Mol Metabol 2014;3:372–83. https://doi.org/10.1016/j.molmet.2014.03.002.Search in Google Scholar PubMed PubMed Central

8. Poggiogalle, E, Jamshed, H, Peterson, CM. Circadian regulation of glucose, lipid, and energy metabolism in humans. Metabolism 2018;84:11–27. https://doi.org/10.1016/j.metabol.2017.11.017.Search in Google Scholar PubMed PubMed Central

9. Van Cauter, E, Polonsky, KS, Scheen, AJ. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev 1997;18:716–38. https://doi.org/10.1210/edrv.18.5.0317.Search in Google Scholar PubMed

10. Sacks, DB, Arnold, M, Bakris, GL, Bruns, DE, Horvath, AR, Lernmark, Å, et al.. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2023;69:808–68. https://doi.org/10.1093/clinchem/hvad080.Search in Google Scholar PubMed

11. Bingham, C, Arbogast, B, Guillaume, GC, Lee, JK, Halberg, F. Inferential statistical methods for estimating and comparing cosinor parameters. Chronobiologia 1982;9:397–439.Search in Google Scholar

12. Koenker, R. Quantile regression for longitudinal data. J Multivariate Anal 2004;91:89. https://doi.org/10.1016/j.jmva.2004.05.006.Search in Google Scholar

13. Haeckel, R, Wosniok, W, Torge, A, Junker, R, Bertram, A, Krebs, A, et al.. Age and sex dependent reference intervals for random plasma/serum glucose concentrations related to different sampling devices and determined by an indirect procedure with data mining: urgent plea for studying the diagnostic efficiency of various concepts proposed to improve the pre-examination phase for determining blood glucose concentrations. J Lab Med 2021;45:95–101. https://doi.org/10.1515/labmed-2020-0064.Search in Google Scholar

14. Wearing, HJ. Spectral analysis in R; 2010. Available from: https://ms.mcmaster.ca/∼bolker/eeid/2010/Ecology/Spectral.pdf.Search in Google Scholar

15. spectralAnalysis: Pre-Process. Visualize and analyse spectral data; 2024. Available from: https://cran.r-project.org/package=spectralAnalysis.Search in Google Scholar

16. Cornelissen, G. Cosinor-based rhythmometry. Theor Biol Med Model 2014;11:1–16. https://doi.org/10.1186/1742-4682-11-16.Search in Google Scholar PubMed PubMed Central

17. Koenker, R, Bassett, G. Tests of linear hypotheses and l1 estimation. Econometrica 1982;50:1577–83. https://doi.org/10.2307/1913398.Search in Google Scholar

18. Haeckel, R, Wosniok, W, Gurr, E, Peil, B. Permissible limits for uncertainty of measurement in laboratory medicine. Clin Chem Lab Med 2015;53:1161–71. https://doi.org/10.1515/cclm-2014-0874.Search in Google Scholar PubMed

19. Haeckel, R, Wosniok, W, Arzideh, F. Equivalence limits of reference intervals for partitioning of population data. Relevant differences of reference limits. LaboratoriumsMedizin 2016;40:199–205. https://doi.org/10.1515/labmed-2016-0002.Search in Google Scholar

20. Arzideh, F, Wosniok, W, Gurr, E, Hinsch, W, Schumann, G, Weinstock, N, et al.. A plea for intra-laboratory reference limits. Part 2. A bimodal retrospective concept for determining reference limits from intra-laboratory databases demonstrated by catalytic activity concentrations of enzymes. Clin Chem Lab Med 2007;45:1043–57. https://doi.org/10.1515/cclm.2007.250.Search in Google Scholar PubMed

21. Kanabrocki, EL, Sothern, RB, Scheving, LE, Halberg, F, Pauly, JE, Greco, JJ, et al.. Ten-year-replicated circadian profiles for 36 physiological, serological and urinary variables in healthy men. Chronobiol Int 1988;5:237–84. https://doi.org/10.3109/07420528809079565.Search in Google Scholar PubMed

22. Sennels, HP, Jørgensen, HL, Goetze, JP, Fahrenkrug, J. Rhythmic 24-hour variations of frequently used clinical biochemical parameters in healthy young males – the Bispebjerg study of diurnal variations. Scand J Clin Lab Invest 2012;72:287–95. https://doi.org/10.3109/00365513.2012.662281.Search in Google Scholar PubMed

23. Sennels, HP, Jørgensen, HL, Hansen, ALS, Goetze, JP, Fahrenkrug, J. Diurnal variation of hematology parameters in healthy young males: the Bispebjerg study of diurnal variations. Scand J Clin Lab Invest 2011;71:532–41. https://doi.org/10.3109/00365513.2011.602422.Search in Google Scholar PubMed

24. Arzideh, F, Özcürümez, M, Albers, E, Haeckel, R, Streichert, T. Indirect estimation of reference intervals using first or last results and results from patients without repeated measurements. J Lab Med 2021;45:103–9. https://doi.org/10.1515/labmed-2020-0149.Search in Google Scholar

25. Jonasdottir, SS, Minor, K, Lehmann, S. Gender differences in nighttime sleep patterns and variability across the adult lifespan: a global-scale wearables study. Sleep 2021;44:zsaa169. https://doi.org/10.1093/sleep/zsaa169.Search in Google Scholar PubMed

26. Simundic, AM, Cornes, M, Grankvist, K, Lippi, G, Nybo, M. Standardization of collection requirements for fasting samples: for the working group on preanalytical phase (WG-PA) of the European federation of clinical chemistry and laboratory medicine (EFLM). Clin Chim Acta 2014;432:33–7. https://doi.org/10.1016/j.cca.2013.11.008.Search in Google Scholar PubMed

27. Stahl, M, Jørgensen, LG, Hyltoft Petersen, P, Brandslund, I, de Fine Olivarius, N, Borch-Johnsen, K. Optimization of preanalytical conditions and analysis of plasma glucose. 1. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Clin Lab Invest 2001;61:169–79. https://doi.org/10.1080/003655101300133612.Search in Google Scholar PubMed

28. Kovatchev, B, Cobelli, C. Glucose variability: timing, risk analysis, and relationship to hypoglycemia in diabetes. Diabetes Care 2016;39:502–10. https://doi.org/10.2337/dc15-2035.Search in Google Scholar PubMed PubMed Central

29. Chai, JH, Ma, S, Heng, D, Yoong, J, Lim, WY, Toh, SA, et al.. Impact of analytical and biological variations on classification of diabetes using fasting plasma glucose, oral glucose tolerance test and HbA1c. Sci Rep 2017;7:13721. https://doi.org/10.1038/s41598-017-14172-8.Search in Google Scholar PubMed PubMed Central

30. Hulmán, A, Færch, K, Vistisen, D, Karsai, J, Nyári, TA, Tabák, AG, et al.. Effect of time of day and fasting duration on measures of glycaemia: analysis from the Whitehall II Study. Diabetologia 2013;56:294–7. https://doi.org/10.1007/s00125-012-2770-3.Search in Google Scholar PubMed

31. Troisi, RJ, Cowie, CC, Harris, MI. Diurnal variation in fasting plasma glucose: implications for diagnosis of diabetes in patients examined in the afternoon. JAMA 2000;284:3157–9. https://doi.org/10.1001/jama.284.24.3157.Search in Google Scholar PubMed


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/cclm-2024-0970).


Received: 2024-08-20
Accepted: 2024-11-14
Published Online: 2024-12-06
Published in Print: 2025-02-25

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. Multi-cancer early detection: searching for evidence
  4. High sensitivity cardiac troponin assays, rapid myocardial infarction rule-out algorithms, and assay performance
  5. Reviews
  6. Consensus statement on extracellular vesicles in liquid biopsy for advancing laboratory medicine
  7. Copeptin as a diagnostic and prognostic biomarker in pediatric diseases
  8. Opinion Papers
  9. The Unholy Grail of cancer screening: or is it just about the Benjamins?
  10. Critical appraisal of the CLSI guideline EP09c “measurement procedure comparison and bias estimation using patient samples”
  11. Tumor markers determination in malignant pleural effusion: pearls and pitfalls
  12. Contribution of laboratory medicine and emerging technologies to cardiovascular risk reduction via exposome analysis: an opinion of the IFCC Division on Emerging Technologies
  13. Guidelines and Recommendations
  14. Recommendations for European laboratories based on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
  15. Genetics and Molecular Diagnostics
  16. Expanded carrier screening for 224 monogenic disease genes in 1,499 Chinese couples: a single-center study
  17. General Clinical Chemistry and Laboratory Medicine
  18. How do experts determine where to intervene on test ordering? An interview study
  19. New concept for control material in glucose point-of-care-testing for external quality assessment schemes
  20. Vitamin B12 deficiency in newborns: impact on individual’s health status and healthcare costs
  21. Analytical evaluation of eight qualitative FIT for haemoglobin products, for professional use in the UK
  22. Colorimetric correcting for sample concentration in stool samples
  23. Reference Values and Biological Variations
  24. Assessment of canonical diurnal variations in plasma glucose using quantile regression modelling and Chronomaps
  25. Inconsistency in ferritin reference intervals across laboratories: a major concern for clinical decision making
  26. Establishing the TSH reference intervals for healthy adults aged over 70 years: the Australian ASPREE cohort study
  27. Hematology and Coagulation
  28. The EuroFlow PIDOT external quality assurance scheme: enhancing laboratory performance evaluation in immunophenotyping of rare lymphoid immunodeficiencies
  29. Clinical value of smear review of flagged samples analyzed with the Sysmex XN hematology analyzer
  30. Cardiovascular Diseases
  31. Evidence for stability of cardiac troponin T concentrations measured with a high sensitivity TnT test in serum and lithium heparin plasma after six-year storage at −80 °C and multiple freeze-thaw cycles
  32. Letters to the Editor
  33. Impact of high-sensitivity cardiac troponin I assay imprecision on the safety of a single-sample rule-out approach for myocardial infarction
  34. Why is single sample rule out of non-ST elevation myocardial infarction using high-sensitivity cardiac troponin T safe when analytical imprecision is so high? A joint statistical and clinical demonstration
  35. Iron deficiency and iron deficiency anemia in transgender populations: what’s different?
  36. The information about the metrological traceability pedigree of the in vitro diagnostic calibrators should be improved: the case of plasma ethanol
  37. Time to refresh and integrate the JCTLM database entries for total bilirubin: the way forward
  38. Navigation between EQA and sustainability
  39. C-terminal alpha-1-antitrypsin peptides as novel predictor of hospital mortality in critically ill COVID-19 patients
  40. Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update
  41. A simple gatekeeping intervention improves the appropriateness of blood urea nitrogen testing
  42. Congress Abstracts
  43. 16ª Reunião Científica da Sociedade Portuguesa de Medicina Laboratorial - SPML
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2024-0970/html
Scroll to top button